AMGN vs XMTR · P/E 24, rev $10.05B vs rev $434.4M
Amgen Inc (AMGN) versus Xometry Inc (XMTR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Xometry Inc (XMTR) is a industrial distribution company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported XMTR revenue for 2026-06-30 was $434.4M. Net income was -$10.6M. XMTR currently screens at market cap $4.81B.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. XMTR currently screens at market cap $4.81B.
Not investment advice. Open the AMGN and XMTR stock pages for the full models.
Not investment advice.